Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands
- 1 August 2007
- Vol. 364 (2), 281-290
- https://doi.org/10.1016/j.virol.2007.02.022
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?PLoS Medicine, 2006
- Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor densityAntiviral Research, 2005
- Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency VirusJournal of Virology, 2005
- The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry InhibitorMolecular Pharmacology, 2005
- Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsBioorganic & Medicinal Chemistry Letters, 2004
- Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell–Expressed and –Secreted) Neutralization of CC Chemokine Receptor 5–Using, Non–Syncytium‐Inducing Virus Variants in the Course of Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2003
- In vivo adaptation of SHIVSF162: Chimeric virus expressing a NSI, CCR5‐specific envelope proteinJournal of Medical Primatology, 1999
- CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In VitroThe Journal of Experimental Medicine, 1997
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997